Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanCombined Modality TherapyBone Marrow TransplantationTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsRemission InductionSalvage TherapyStem CellsHematopoietic Stem Cell MobilizationLymphoma, Non-HodgkinDisease-Free SurvivalHematopoietic Stem CellsRecurrenceHodgkin DiseaseGraft vs Host DiseaseMyeloablative AgonistsEtoposideCarmustineLiver TransplantationCyclophosphamideCytarabineBone Marrow PurgingHematologic NeoplasmsWhole-Body IrradiationSurvival RateGraft SurvivalVincristineAntigens, CD34Survival AnalysisRetrospective StudiesBusulfanThiotepaKidney TransplantationDexamethasoneLymphoma, Mantle-CellAmyloidosisLeukapheresisGranulocyte Colony-Stimulating FactorCell TransplantationFollow-Up StudiesPrognosisThalidomideAntibodies, Monoclonal, Murine-DerivedBoronic AcidsAntineoplastic Agents, AlkylatingPyrazinesTime FactorsTransplantation ChimeraDoxorubicinTissue DonorsMesenchymal Stem Cell TransplantationLymphoma, FollicularPrednisoneAutograftsLymphomaLymphoma, T-Cell, PeripheralCord Blood Stem Cell TransplantationNeoplasm, ResidualHeart TransplantationLeukemia, Myeloid, AcuteHematopoiesisImmunosuppressive AgentsIfosfamideLung TransplantationMyelodysplastic SyndromesPodophyllotoxinAntineoplastic AgentsIdarubicinInduction ChemotherapyBone MarrowBlood Component RemovalLymphoma, Large B-Cell, DiffuseBone Marrow CellsCell DifferentiationHistocompatibility TestingMaintenance ChemotherapyLeukemiaTransplantation ImmunologyEmbryonic Stem CellsGraft RejectionFeasibility StudiesOrgan TransplantationProspective StudiesBlood Transfusion, AutologousAntibodies, MonoclonalLymphoma, B-CellGraft vs Tumor EffectEnteropathy-Associated T-Cell LymphomaHistocompatibilityLeukemia, Plasma CellCells, CulturedAdult Stem CellsInfusions, Spinal